Pasithea Therapeutics Statistics
NASDAQ: KTTAHealthcareBiotechnologyUSD
0.4409-0.0025 (-0.56%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pasithea Therapeutics by the numbers
Pasithea Therapeutics has a market capitalization of $14.7 million based on 33.41M shares outstanding. With trailing EPS of $-1.59, Pasithea Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.7% below its 50-day average and 35.5% below its 200-day average.
Average daily trading volume is 225.69K shares, or about $99,505 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KTTA valuation vs. peer median
| Metric | KTTA | Peer median | Difference |
|---|---|---|---|
| Market cap | $14.73M | $15.47M | -5% |
| Avg. volume | 225.69K | 474.41K | -52% |
Peer median across 8 companies: DARE, TVRD, HIND, AEON, TCRX, ALLR, MRKR, LPCN.
Valuation
- Market cap
- $14.73M
- EPS (TTM)
- $-1.59
- Shares outstanding
- 33.41M
Price and trading
- Previous close
- 0.4434
- Open
- 0.4519
- Day range
- 0.4409 – 0.4675
- 52-week range
- 0.281 – 2.06
- 52-week change
- -46.23%
- Beta
- —
- Volume
- 56.16K
- Average volume
- 225.69K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 14.73M
- Forward Pe
- -0.96
- Eps
- -1.59
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.06
- Week52 Low
- 0.28
- Avg Volume
- 225.69K
- Shares Outstanding
- 33.41M
- Ma50
- 0.50
- Ma200
- 0.68
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -78.60%
- Pct From52w Low
- 56.90%